Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2015-12-21 Regulatory Filings
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Genmab når milestone på USD 3 mio. i DuoBody platform samarbejdet med Janssen
Regulatory Filings Classification · 95% confidence The document is a corporate announcement ('Selskabsmeddelelse') from Genmab regarding a milestone payment of USD 3 million from a partnership with Janssen. It details the nature of the milestone, the impact on the company's financial outlook, and provides background on the technology platform. As it is a general regulatory announcement regarding company operations and financial milestones that does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS).
2015-12-21 English
Genmab når milestone på USD 3 mio. i DuoBody platform samarbejdet med Janssen
Regulatory Filings Classification · 95% confidence The document is a 'Company Announcement' from Genmab regarding a $3 million milestone payment received from a collaboration with Janssen. It details the nature of the milestone, the financial implications (or lack thereof regarding guidance), and provides background on the technology platform. Since it is a specific corporate announcement regarding a business development milestone and does not fit into categories like financial reports, proxy statements, or board changes, it is classified as a general regulatory announcement.
2015-12-21 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) in Danish and details a specific business event: Genmab reaching a milestone payment of USD 3 million from Janssen related to their DuoBody platform collaboration. This is a specific, material business update concerning partnerships, technology progress, and financial milestones, but it is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement. It is a targeted announcement of a corporate development. Given the options, this type of announcement, which details specific business progress and financial implications outside of standard periodic reporting, fits best under the general category of Regulatory Filings (RNS) as a catch-all for material, non-standard announcements, or potentially a Capital/Financing Update (CAP) if the focus was purely on the cash inflow, but RNS is broader for company news. Since it is a formal, dated announcement of a specific corporate event (milestone achievement), RNS is the most appropriate general regulatory filing category when a more specific one like DIV or CAP doesn't perfectly capture the nature of the update (which is partnership progress). The length (6778 chars) is substantial enough that it is the announcement itself, not just a notice of publication (RPA).
2015-12-18 Danish
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is titled 'Company Announcement' and details a specific business event: Genmab achieving a $3 million milestone payment from Janssen related to their DuoBody collaboration. This type of announcement, focusing on partnership progress, milestone payments, and business development updates, is characteristic of general corporate news releases rather than mandatory regulatory filings like 10-K, IR, or ER. Since it is a specific business update that doesn't fit the definitions for Capital/Financing (CAP), M&A (TAR), or Director's Dealing (DIRS), the most appropriate classification is a general Regulatory Filing (RNS), which serves as the fallback for miscellaneous corporate announcements not covered by more specific codes. The document length (6365 chars) is substantial enough that it is the primary report, not just a notice of a report (RPA).
2015-12-18 English
Genmab når milestone på USD 3 mio. for fremskridt i DuoBody platform samarbejdet med Janssen
Regulatory Filings Classification · 95% confidence The document is a corporate announcement (Selskabsmeddelelse) from Genmab regarding the achievement of a financial milestone in their partnership with Janssen. It details the specific milestone payment amount (USD 3 million), the context of the DuoBody platform collaboration, and confirms that this event does not impact their 2015 financial guidance. As this is a general regulatory announcement regarding business operations and milestones that does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing.
2015-12-18 English
Genmab når milestone på USD 3 mio. for fremskridt i DuoBody platform samarbejdet med Janssen
Regulatory Filings Classification · 95% confidence The document is a 'Company Announcement' from Genmab regarding the achievement of a financial milestone in a collaboration with Janssen. It details the nature of the milestone, the financial impact (or lack thereof on guidance), and provides background on the technology platform. It does not fit into specific categories like 10-K, CT, or DIRS. Since it is a general regulatory/corporate announcement that does not fit into the more specific categories provided, it is classified as a Regulatory Filing (RNS).
2015-12-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.